The prevalence of growth hormone deficiency in survivors of subarachnoid haemorrhage: results from a large single centre study
Crossref DOI link: https://doi.org/10.1007/s11102-017-0825-7
Published Online: 2017-08-18
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Giritharan, Sumithra
Cox, Joanna
Heal, Calvin J.
Hughes, David
Gnanalingham, Kanna
Kearney, Tara
Funding for this research was provided by:
Pfizer UK (WI184597)
License valid from 2017-08-18